Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Wayne Hall

57 indexed publications match this author name.

ORCID: 0000-0003-1984-0096
OpenAlex: https://openalex.org/A5137990709

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 23 Mechanism of Action 21 Receptor Pharmacology 16 Anxiety 15 Safety 13 Review Article 12 Clinical Trial 12 Addiction 12 Microdosing 9 Observational Study 9 Brain Imaging 8 Treatment-Resistant Depression 8

Journals

PsyArXiv 4 Journal of psychopharmacology (Oxford, England) 3 ClinicalTrials.gov 3 Therapeutic advances in psychopharmacology 3 Psychopharmacology 2 Neuropharmacology 2 Addiction (Abingdon, England) 2 Addiction 2

Publication history

Classic psychedelics and personality: An updated systematic review.Journal of psychopharmacology (Oxford, England) · 2026-08-01 A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study.The International journal on drug policy · 2026-08-01 Daily self-assessment within a regimen of microdosing indicates enhanced psychological functioning on microdosing days relative to non-microdosing days.Psychopharmacology · 2026-07-01 Anthracaurisin A─Discovery of a Cytotoxic -Sesquiterpene Dimer from Patagonian.Journal of natural products · 2026-06-26 Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use DisorderClinicalTrials.gov · 2026-03-30 Journeying into Right Relations: Scientists Turn to Psilocybin to Shift Psychological Burdens of Global Environmental Change and Find Transformational Pathways ForwardAction Research · 2026-03-01 Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials.Neuropharmacology · 2026-02-15 Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trials.Neuropharmacology · 2026-02-01 Toward Standardized Products Containing Biomass of Psilocybe Cubensis Fungi.Journal of AOAC International · 2026-01-01 Psychedelic-induced behavioral and developmental effects on zebrafish: a systematic review.Progress in neuro-psychopharmacology & biological psychiatry · 2025-10-02 Understanding psilocybin mushrooms and aiding in setting standards for a burgeoning industry in JamaicaPhytochemistry Letters · 2025-10-01 Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging StudyClinicalTrials.gov · 2025-08-20 Stronger visual surround suppression under psilocybin: A psychophysical and EEG pilot studyJournal of Vision · 2025-07-15 Beyond prohibition: A public health analysis of naturalistic psychedelic useJournal of Psychedelic Studies · 2025-07-03 High-quality draft genomes of ecologically and geographically diverse species.Microbiology resource announcements · 2025-02-11 International Drug Policy Study Trends With Psychedelic Drugs: A Spotlight on Psilocybin, LSD, and MDMADrug and Alcohol Dependence · 2025-02-01 Crafting effective regulatory policies for psychedelics: What can be learned from the case of cannabis?Addiction (Abingdon, England) · 2025-02-01 Association of Hallucinogen Persisting Perception Disorder with Trait Neuroticism and Mental Health Symptoms.Journal of psychoactive drugs · 2025-01-01 Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money.Annual review of psychology · 2025-01-01 Disentangling debate about therapeutic and recreational use of psychedelicsAddiction · 2024-12-15 Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06 Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trial.Journal of vision · 2024-11-04 A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia.Addiction (Abingdon, England) · 2024-09-01 Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical studyPsyArXiv · 2024-01-11 Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical studyPsyArXiv · 2024-01-11 [Psychedelics and treatment of mental disorders: A survey of attitudes and knowledge among psychiatrists, general practitioners and psychologists in Iceland].Laeknabladid · 2023-11-01 In silico characterization of the psilocybin biosynthesis pathway.Computational biology and chemistry · 2023-06-01 Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17 Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study.Psychopharmacology · 2022-06-01 Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.Expert opinion on drug safety · 2022-06-01 Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.Journal of psychopharmacology (Oxford, England) · 2022-01-01 What can we learn from the history of research on psychedelic drugs in the addictions?Addiction · 2021-08-12 Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trialsPsyArXiv · 2021-06-14 Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trialsPsyArXiv · 2021-06-14 The need for publicly funded research on therapeutic use of psychedelic drugsWorld Psychiatry · 2021-05-18 Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.Journal of psychopharmacology (Oxford, England) · 2021-04-01 Psychedelic Medicines in Major Depression: Progress and Future Challenges.Advances in experimental medicine and biology · 2021-01-01 The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges.Risk management and healthcare policy · 2021-01-01 Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.Journal of clinical psychopharmacology · 2021-01-01 Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study.Frontiers in psychiatry · 2021-01-01 Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers.Frontiers in psychiatry · 2021-01-01 Polypharmacology or "Pharmacological Promiscuity" In Psychedelic Research: What Are We Missing?ACS chemical neuroscience · 2020-10-21 Hallucinogens/psychedelics resurrected as new tools in psychiatric therapyBrazilian Journal of Psychiatry · 2020-05-31 Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.Neuroscience and biobehavioral reviews · 2020-01-01 Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer.BMC psychiatry · 2019-10-28 The effects of psilocybin microdosing on perception: a double-blind controlled studyOSF Preprints (OSF Preprints) · 2019-01-30 Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.Therapeutic advances in psychopharmacology · 2019-01-01 Psychedelics and Personality.ACS chemical neuroscience · 2018-10-17 Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.Expert review of clinical pharmacology · 2018-09-01 Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.Therapeutic advances in psychopharmacology · 2017-04-01 Maddening Therapies: How Hallucinogens Morphed into Novel TreatmentsCurrent psychiatry · 2017-01-01 Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging.Neuroscience and biobehavioral reviews · 2016-12-01 Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.Therapeutic advances in psychopharmacology · 2016-06-01 The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network.PloS one · 2015-01-01 Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term MeditatorsClinicalTrials.gov · 2014-05-20 A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students.Drug and alcohol dependence · 2013-06-01 Abuse of indigenous psilocybin mushrooms: a new fashion and some psychiatric complications.The British journal of psychiatry: the journal of mental science · 1978-06-01

Author directory